Question 1

What specific benefits might I expect from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer clinical trial (NCT01632306). Contact the study team or your healthcare provider for specific answers.

Question 2

How does LY2090314 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer clinical trial (NCT01632306). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the treatments being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer clinical trial (NCT01632306). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer clinical trial (NCT01632306). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of tests or procedures would I need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer clinical trial (NCT01632306). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any support for travel or expenses related to participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer clinical trial (NCT01632306). Contact the study team or your healthcare provider for specific answers.

What this study is about